These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14050947)

  • 21. The treatment of haemorrhage in von Willebrand's disease and the blood level of factor VIII (AHG).
    BIGGS R; MATTHEWS JM
    Br J Haematol; 1963 Apr; 9():203-14. PubMed ID: 13971121
    [No Abstract]   [Full Text] [Related]  

  • 22. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand's disease in two families. Case reports with a contribution to the management of chronic intestinal hemorrhages.
    Salomon H; Tatarski I
    Isr J Med Sci; 1965 Jul; 1(4):866-9. PubMed ID: 5295184
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

  • 26. Open-heart surgery in von Willebrand's disease.
    Aris A; Pisciotta AV; Hussey CV; Gale H; Lepley D
    J Thorac Cardiovasc Surg; 1975 Feb; 69(2):183-7. PubMed ID: 1078707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnosis of von Willebrand's disease.
    Bowie EJ; Owen CA
    Ann Clin Lab Sci (1971); 1971; 1(1):85-91. PubMed ID: 4949765
    [No Abstract]   [Full Text] [Related]  

  • 28. [VON WILLEBRAND'S DISEASE (ANGIOHEMOPHILIA A). CASE CONTRIBUTION AND PHYSIOPATHOLOGIC OBSERVATIONS].
    ASCARI E; BARBIERI U; GOBBI F
    Prog Med (Napoli); 1964 Nov; 20():749-59. PubMed ID: 14291804
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of plasma and Cohn's fraction I on the Duke and Ivy bleeding times in von Willebrand's disease.
    BORCHGREVINK CF; EGEBERG O; GODAL HC; HJORT PF
    Acta Med Scand; 1963 Feb; 173():235-42. PubMed ID: 14013864
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HEMORRHAGE IN VON WILLEBRAND'S DISEASE, ITS NATURE AND THERAPY].
    HRUBISKO M; HRUBISKOVA K
    Bratisl Lek Listy; 1964; 2():25-33. PubMed ID: 14167438
    [No Abstract]   [Full Text] [Related]  

  • 32. ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI-HAEMOPHILIC FACTOR.
    SHERLOCK M; GUTHRIE C; BLOMBACK M; BLOMBAUCK B
    Med J Aust; 1963 Sep; 15():453-5. PubMed ID: 14048444
    [No Abstract]   [Full Text] [Related]  

  • 33. ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI-HAEMOPHILIC FACTOR.
    SHERLOCK M; GUTHRIE C; BLOMBAECK M; BLOMBAECK B
    Med J Aust; 1963 Sep; 15():453-5. PubMed ID: 14054485
    [No Abstract]   [Full Text] [Related]  

  • 34. A USEFUL PHOTOMETRIC TEST FOR THE DIAGNOSIS OF VON WILLEBRAND'S DISEASE.
    VAINER H; CAEN JP
    J Clin Pathol; 1964 Mar; 17(2):191-3. PubMed ID: 14149949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Willebrand's disease.
    Bowie EJ; Owen CA
    Med Clin North Am; 1972 Jan; 56(1):275-84. PubMed ID: 4550191
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.
    Gazengel C; Fischer AM; Schlegel N; Rothschild C; Torchet MF; Dautzenberg MD; Aujard Y
    Nouv Rev Fr Hematol (1978); 1988; 30(4):225-7. PubMed ID: 3143100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ELEVATION OF FACTOR VIII (ANTIHEMOPHILIC FACTOR) DURING PREGNANCY IN NORMAL PERSONS AND IN A PATIENT WITH VON WILLEBRAND'S DISEASE.
    STRAUSS HS; DIAMOND LK
    N Engl J Med; 1963 Dec; 269():1251-2. PubMed ID: 14060572
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
    J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new method of demonstrating the effect of therapy in von Willebrand's disease.
    Sutor AH; Bowie EJ; Owen CA
    Mayo Clin Proc; 1971 May; 46(5):345-6. PubMed ID: 5314172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.